$33.93▴ 0.38%
End-of-day close · 2026-08-06
What most investors miss
Trends, drivers and alerts — the full picture.
Profit → Cash
$17.90MTTM operating cash
Pre-profit
It generates operating cash even though it has no reported profit yet.
Valuation
Not enough data yet
Not enough valuation history to place this in context.
Revenue growth
+14.9%year over year
Healthy
Revenue is growing at a steady pace.
Leverage
Lowdebt to assets
Strong
Very low debt relative to its asset base.
More coming: dilution / share-count creep.
✦ The read
BioLife Solutions, Inc. is pre-profit. It generates operating cash even though it has no reported profit yet. Revenue is growing at a steady pace. Very low debt relative to its asset base.
Key numbers
Valuation
EPS (TTM)$-0.07
TTM (trailing 12 months, through fiscal Q1 FY2026)
Profitability
Net margin-3.0%
TTM (trailing 12 months, through fiscal Q1 FY2026)
Size
Revenue (TTM)$99.77M
TTM (trailing 12 months, through fiscal Q1 FY2026)
Recent news
Sentiment · last 30 days1 article
0 bullish0 neutral1 bearish
Signals and key numbers are from the fiscal Q1 FY2026 filing. Price freshness: end-of-day close on Free, 15-min delayed on Pro.